Proudly, Medtech Insight's 32nd In3 Event
This event will showcase a single track of 50 early- to late-stage med device companies seeking investment and/or strategic partnership (the majority presenting at an In3 for the first time), with each 10-minute presentation followed by a one-hour break-out session in a private conference room.
"Investment In Innovation (In3) East"
October 22-24, 2008
The Westin Copley Place, Boston, MA
Immediately following Medical Device Investor Day
Register online
MORE THAN 30 PRESENTING COMPANIES CONFIRMED TO DATE:
AugmentRx Medical, Inc. (First-Time Presenter)
Shelburne, VT AugmentRx(TM): Injectable porous scaffolds, spheres and composites with fully interconnected pores. Nonmigratory, nonantigenic providing sustainable tissue volume and stability for multiple applications.
Axogen, Inc. (First-Time Presenter)
Gainesville, FL
BoneGrafix (First-Time Presenter)
Rockfield, MD
Cardiola, Ltd.
Winterthur, Switzerland Non-invasive Chronic Heart Failure treatment device with CE certification using patented Muscular Counter Pulsation (MCP) technology.
CardioMag Imaging, Inc. (First-Time Presenter)
Schenectady, NY
Ceragenix Pharmaceuticals
Denver, CO Ceragenix Pharmaceuticals is developing its "Cerashield" line of antimicrobial coatings to prevent microbial colonization and biofilm formation of endotracheal tubes and other indwelling medical devices.
Cerapedics, Inc.
Westminster, CO Cerapedics, Inc. is developing and commercializing innovative osteobiologic products based on its proprietary small peptide technology for spine, trauma and orthopaedic applications.
Cohera Medical, Inc.
Pittsburgh, PA Cohera Medical is developing TissuGlu™, a biodegradable surgical adhesive for seroma reduction in plastic surgery.
Core Essence Orthopaedics LLC. (First-Time Presenter)
Yardley, PA
Curative Biosciences, Inc. (First-Time Presenter)
Waltham, MA
Delcath Systems, Inc. (First-Time Presenter)
New York, NY Delcath is a developmental stage medical device company testing a high-dose drug delivery system for the treatment of liver cancers.
DermTech International
La Jolla, CA DermTech is developing non-invasive molecular diagnostics for the early detection of melanoma and other diseases, theranostics and drug development.
eCardio Diagnostics
The Woodlands, TX eCardio Diagnostics, www.eCardio.com, is the leading North American provider of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring, and subsequent clinical management of cardiac arrhythmias.
EndoSphere Inc. (First-Time Presenter)
Redwood City, CA
EyeMarker Systems, Inc. (First-Time Presenter)
Morgantown, WV EyeMarker Systems - Automated handheld RTD1000 (3lbs) provides rapid (3 minutes), non-invasive triage and detection of pre-symptomatic exposure to systemic diseases, toxins, and internal injury via the eye.
Healionics Corporation
Redmond, WA 3D tissue scaffold materials and structures providing enhanced biocompatibility and bio-integration of medical devices.
LineaGen, Inc. (First-Time Presenter)
Salt Lake City, UT Content-based biomarker discovery company focused on the commercialization of novel, patentable diagnostic tests.
MicroTransponder Inc. (First-Time Presenter)
Dallas, TX MicroTransponder has developed a wireless neurostimulation device to treat refractory chronic pain. Our device is 100 times smaller than current technology and injectable via a minimally invasive hypodermic needle.
Minnow Medical
San Diego, CA New catheter treatment to restore blood flow to arteries by reducing plaque volume and increasing the artery diameter.
mNemoscience GmbH
Aachen, Germany mNemoscience is pioneering the design and manufacture of innovative biocompatible shape memory polymers (BIO-SMP) which can be programmed to change shapes and rigidity when an initiating stimulus, such as e.g. change in temperature, is applied.
MTM Laboratories (First-Time Presenter)
Westborough, MA Biomarkers for the screening and diagnosis of cancers; initial focus is on Cervical Cancer.
nContact Surgical, Inc. (First-Time Presenter)
Morrisville, NC nContact Surgical is focused on commercializing novel cardiac coagulation systems that enable endoscopic, “port access” minimally invasive for the treatment of atrial fibrillation.
Nerites Corporation
Madison, WI Nerites Corporation develops fully-synthetic, water-resistant adhesives, sealants, and coatings for internal medical use. The hydrogel technology can be used to close internal tears or incisions, to seal tissues and prevent leakage and infection, and to affix synthetic or biologic medical devices.
Neurobionix
Quebec, Canada Victhom's Neurobionix business unit focuses on the development and commercialization of technologies and products involving implantable devices that features neurosensing and neurostimulation components, integrated with artificial intelligence
Osprey Medical (First-Time Presenter)
St. Paul, MN Osprey Medical’s CINCOR™ system is designed to prevent contrast media, used in coronary procedures, from causing kidney damage.
PEAK Surgical, Inc. (First-Time Presenter)
Palo Alto, CA PEAK Surgical’s technology provides the precision of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral tissue damage
Polymedix, Inc.
Radnor, PA Novel anti-microbial polymeric coatings for devices and implants.
Sentinel Group LLC. (First-Time Presenter)
Grand Rapids, MI A removable minimally invasive device to treat obesity by inducing satiety in the esophageal / cardiac portion of the stomach placed via endoscopy (www.SentinelGroupLLC.com).
Sherlock-NMD (First-Time Presenter)
Hidden Valley Lake, CA Sherlock-NMD is a non-invasive biomechanical diagnostic system that records and analyzes human range of motion (ROM) in a full 3D environment. It provides real-time diagnostic images of neuro-muscular-skeletal function and dysfunction of the human body in motion.
Spinal Elements
Carlsbad, CA Zyre™ Facet Arthroplasty System Minimally invasive, tissue sparing, reversible.
Symbios Medical
Indianapolis, IN The Symbios GOPump™ Rapid Recovery System provides postoperative pain relief for patients more effectively than narcotics.
ViOptix, Inc. (First-Time Presenter)
Fremont, CA
Vivostat A/S
Alleroed, Denmark Vivostat A/S manufactures and sells a surgical sealant and a gel to treat chronic wounds. Both are based on the individual patients own blood. A third product can be used as a drug delivery media for topical use.
Xylos Corporation
Langhorne, PA Xylos Corporation is a medical device company that develops unique biomaterials based on proprietary biocellulose technology for the treatment, repair and replacement of human tissue.
OTHER EVENT HIGHLIGHTS
October 22, 2008
5:30-7:30 p.m.
Registration and Welcome Reception
Pre-conference panel discussion - TBA
October 23, 2008
Keynote Panel Discussion: Stories behind How Financing Deals got Done
• Why we invested in certain technologies/clinical spaces
• What kind of due diligence got done
• How valuations were determined
• What was the rationale behind the deal from an in investment point of view
Panelists:
- David Milne, Managing Partner, SV Life Science Advisers LP
- Kevin Connors, General Partner, Spray Venture Partners
- Amir Nashat, General Partner, Polaris Ventures
Thursday evening, October 23: Presenting Company Product Exhibition/Networking Reception
October 24, 2008
Panel Discussion: FDA Update - Tips for Smooth and Successful Interactions with CDRH
• Get the latest news from Washington on IDEs, PMA review, the 510(k) process, device reclassifications and user fees
• Learn how to use the new Interactive Review process for pre-market submissions
• Understand CDRH’s changing expectations for 510(k) clearance
Panelists TBA
IN3 EAST CO-SPONSORS:
AdvaMed, Averion, Battelle, Business Wire, Edwards Angell Palmer & Dodge, MDMA, Medmarc and The Hartford, Medical Capital Advisors, The MedTech Group, Push-Med, Ronald Trahan Associates, TATRC, and FDC Reports' The Gray Sheet.
REGISTER FOR INVESTOR DAY AND IN3 EAST TOGETHER AND SAVE $500 BEFORE AUGUST 31ST!
Registration fee for Medical Device Investor Day Only: $795
Registration fee for both Medical Device Investor Day and Investment In Innovation (In3) East: Save $500 in total before August 31, 2008 only -- $300 off the regular Investor Day registration fee (you pay $495), plus $200 off the regular In3 East registration fee through August 31 (you pay $1495): A total fee of $1990 per attendee ($500 total discount) for both do-not-miss investment and partnering events. Additional discounts apply when registering more than one attendee at a time.
Call either of the numbers below with any questions or to register for one or both of these events, or visit www.windhover.com/investorday and www.windhover.com/in3east08.
Thank you for your interest in our exciting October device investment and partnering events -- we look forward to hopefully having you with us in Boston.
Kristy Grimes
Sales Manager
Medtech Insight/Windhover Information, an Elsevier Company
Tel: 480-985-9512
or 888-202-5939 toll-free in the U.S.
[email protected]
